<figure><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iTkyYkvPcNUs/v8/-1x-1.png"><figcaption><div></div><div>Source: Bloomberg Intelligence</div></figcaption></figure><p>Vaccine-maker Moderna is also a data company, and that&#x2019;s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence&#x2019;s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a wide range of related topics, from the use of mRNA technology to applying data for speeding up R&amp;D for rare diseases. The discussion also touches on the deployment of generative AI across different parts of the Moderna-platform tech stack.</p>

Moderna's CIO Brad Miller discusses the company's use of platform and AI with Bloomberg Intelligence's Sam Fazeli and Mandeep Singh. The episode touches on a wide range of topics from the use of mRNA technology to applying data for speeding up R&D for rare diseases. We also discuss the deployment of gen AI across different parts of the Moderna platform tech stack.

Moderna and Drug Discovery with AI: Tech Disruptors

Hub Poster

Understand every aspect of the global economy – and know how to make your next move.